Skip to content

CHICAGO EQUITY PARTNERS LLC: PCRX position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of CHICAGO EQUITY PARTNERS LLC on PCRX, newest first. How the timeline and the estimate are built.

CHICAGO EQUITY PARTNERS LLC held 0 PCRX shares at 2019-09-30 per its 13F-HR filed 2019-10-30.

the latest 13F is the newest step

  1. period ended2019-09-30
    13F 0 shares
    Change vs previous 13F -102,125 shares

    13F-HR 0001085146-19-002673 filed by CHICAGO EQUITY PARTNERS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2019-06-30
    13F 102,125 shares
    Change vs previous 13F +32,585 shares

    0.2% of the 13F portfolio, value $4,441,000.

    13F-HR 0001085146-19-002053 filed by CHICAGO EQUITY PARTNERS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2019-03-31
    13F 69,540 shares
    Change vs previous 13F -20,720 shares

    0.1% of the 13F portfolio, value $2,647,000.

    13F-HR 0001085146-19-001514 filed by CHICAGO EQUITY PARTNERS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2018-12-31
    13F 90,260 shares
    Change vs previous 13F -3,380 shares

    0.16% of the 13F portfolio, value $3,883,000.

    13F-HR 0001085146-19-000329 filed by CHICAGO EQUITY PARTNERS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2018-09-30
    13F 93,640 shares
    Change vs previous 13F not available

    0.14% of the 13F portfolio, value $4,602,000.

    13F-HR 0001085146-18-002465 filed by CHICAGO EQUITY PARTNERS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).